Europe Joint Pain Injection Market Forecast to 2028 - By Size, Share, Growth by End User and Forecast| Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Joint Pain Injection Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Joint Pain Injection Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increase in joint-related disorders
5.1.2 Rising demand for non-invasive treatments

5.2 Market Opportunities

5.2.1 Expansion in orthopedic and pain management sectors
5.2.2 Rise in non-invasive joint treatments

5.3 Future Trends

5.3.1 Advances in minimally invasive joint pain therapies
5.3.2 Rise in patient-specific treatments

5.4 Impact of Drivers and Restraints

6. Europe Joint Pain Injection Market Regional Analysis

6.1 Europe Joint Pain Injection Market Overview

6.2 Europe Joint Pain Injection Market Revenue 2019-2028 (US$ Million)

6.3 Europe Joint Pain Injection Market Forecast Analysis

7. Europe Joint Pain Injection Market Analysis – by Drugs

7.1 Hyaluronic Acid

7.1.1 Overview
7.1.2 Hyaluronic Acid: Europe Joint Pain Injection Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Corticosteroid

7.2.1 Overview
7.2.2 Corticosteroid: Europe Joint Pain Injection Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Joint Pain Injection Market Analysis – by Joint Type

8.1 Knee

8.1.1 Overview
8.1.2 Knee: Europe Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Foot and Ankle

8.2.1 Overview
8.2.2 Foot and Ankle: Europe Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Shoulder and Elbow

8.3.1 Overview
8.3.2 Shoulder and Elbow: Europe Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Hip

8.4.1 Overview
8.4.2 Hip: Europe Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Joint Pain Injection Market Analysis – by Distribution Channel

9.1 Retail Pharmacies

9.1.1 Overview
9.1.2 Hip: Europe Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Hospitals Pharmacies

9.2.1 Overview
9.2.2 Hip: Europe Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Joint Pain Injection Market – Europe Analysis

10.1 Europe

10.1.1 Europe Joint Pain Injection Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 Europe Joint Pain Injection Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 UK: Europe Joint Pain Injection Market Breakdown, by Drugs
10.1.1.1.2 UK: Europe Joint Pain Injection Market Breakdown, by Joint Type
10.1.1.1.3 UK: Europe Joint Pain Injection Market Breakdown, by Distribution Channel

10.1.1.2 Germany: Europe Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Germany: Europe Joint Pain Injection Market Breakdown, by Drugs
10.1.1.2.2 Germany: Europe Joint Pain Injection Market Breakdown, by Joint Type
10.1.1.2.3 Germany: Europe Joint Pain Injection Market Breakdown, by Distribution Channel

10.1.1.3 France: Europe Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 France: Europe Joint Pain Injection Market Breakdown, by Drugs
10.1.1.3.2 France: Europe Joint Pain Injection Market Breakdown, by Joint Type
10.1.1.3.3 France: Europe Joint Pain Injection Market Breakdown, by Distribution Channel

10.1.1.4 Russia: Europe Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Russia: Europe Joint Pain Injection Market Breakdown, by Drugs
10.1.1.4.2 Russia: Europe Joint Pain Injection Market Breakdown, by Joint Type
10.1.1.4.3 Russia: Europe Joint Pain Injection Market Breakdown, by Distribution Channel

10.1.1.5 Italy: Europe Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Italy: Europe Joint Pain Injection Market Breakdown, by Drugs
10.1.1.5.2 Italy: Europe Joint Pain Injection Market Breakdown, by Joint Type
10.1.1.5.3 Italy: Europe Joint Pain Injection Market Breakdown, by Distribution Channel

10.1.1.6 Rest of Europe: Europe Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Joint Pain Injection Market Breakdown, by Drugs
10.1.1.6.2 Rest of Europe: Europe Joint Pain Injection Market Breakdown, by Joint Type
10.1.1.6.3 Rest of Europe: Europe Joint Pain Injection Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Joint Pain Injection Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Chugai Pharmaceutical Co., Ltd.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bioventus Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Fidia Pharma USA Inc.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Seikagaku Corporation

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Ferring B.V.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Sanofi

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Anika Therapeutics, Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Teva Pharmaceutical Industries Ltd.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights